Submission of pathologic material for biologic research and testing-what are the issues?
- PMID: 11745886
- DOI: 10.1002/mpo.1241
Submission of pathologic material for biologic research and testing-what are the issues?
Comment on
-
Pathology and biology guidelines for resectable and unresectable neuroblastic tumors and bone marrow examination guidelines.Med Pediatr Oncol. 2001 Dec;37(6):492-504. doi: 10.1002/mpo.1242. Med Pediatr Oncol. 2001. PMID: 11745887
Similar articles
-
STAT testing? A guideline for meeting clinician turnaround time requirements. Practice parameter.Am J Clin Pathol. 1996 Jun;105(6):671-5. doi: 10.1093/ajcp/105.6.671. Am J Clin Pathol. 1996. PMID: 8659440
-
Improving specimen practices to reduce errors.AORN J. 2005 Dec;82(6):1051-4. doi: 10.1016/s0001-2092(06)60258-5. AORN J. 2005. PMID: 16478084 No abstract available.
-
Exploring the College of American Pathologists Electronic Cancer Checklists: What They Are and What They Can Do for You.Arch Pathol Lab Med. 2021 Apr 1;145(4):392-398. doi: 10.5858/arpa.2020-0239-ED. Arch Pathol Lab Med. 2021. PMID: 33238006 No abstract available.
-
College of American Pathologists 2003 fresh frozen serum proficiency testing studies.Arch Pathol Lab Med. 2005 Mar;129(3):292-3. doi: 10.5858/2005-129-292-COAPFF. Arch Pathol Lab Med. 2005. PMID: 15737018 Review. No abstract available.
-
Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis. A joint proposal of the European Society of Uropathology and the Uropathology Working Group.Virchows Arch. 2004 Aug;445(2):103-10. doi: 10.1007/s00428-004-1039-8. Epub 2004 Jun 8. Virchows Arch. 2004. PMID: 15185074 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical